Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Postoperative Hemorrhage 1Postoperative Complications 1Polyposis, Gastric 1Ovarian Neoplasms 1Myofibroma 1Leiomyoma 1Hemorrhage 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Blood Loss, Surgical 1

Interventions

Leucovorin 4Fluorouracil 3Oxaliplatin 2Laparoscopy 2Cetuximab 2Capecitabine 2tislelizumab 1ferric maltol 1envafolimab 1Tranexamic Acid 1Surgical Procedures, Operative 1Ropivacaine 1Propofol 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Nitrous Oxide 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Motivational Interviewing 1Isoflurane 1Irinotecan 1Ipilimumab 1Immunohistochemistry 1HMPL-013 1Folfox protocol 1Filgrastim 1Fentanyl 1Epinephrine 1Endoscopic Mucosal Resection 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Colonic Neoplasms × Tranexamic Acid × Clear all
NCT05345613 2026-01-13

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Assaf-Harofeh Medical Center

Phase 4 Recruiting
200 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡